Drugs
March 2005: Additions and Deletions to the Drug Product List
24th Edition: Cumulative Supplement Number 3
[Prescription - OTC]
NOTE: The format for the Monthly Additions/Deletions Drug Product List has changed as of the July Cumulative Supplement (CS) of the 21st Edition to mirror the CS. Refer to the CS Preface section 1.5 CUMULATIVE SUPPLEMENT LEGEND.
ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST
ACETAMINOPHEN; TRAMADOL HYDROCHLORIDE TABLET; ORAL >A> ACETAMINOPHEN AND TRAMADOL HCL >A> AB KALI LABS 325MG;37.5MG N76475 001 Apr 21, 2005 Mar NEWA ULTRACET >D> + ORTHO MCNEIL 325MG;37.5MG N21123 001 Aug 15, 2001 Mar CFTG >A> AB + 325MG;37.5MG N21123 001 Aug 15, 2001 Mar CFTG ACRIVASTINE; PSEUDOEPHEDRINE HYDROCHLORIDE CAPSULE; ORAL SEMPREX-D >D> + CELLTECH PHARMS 8MG;60MG N19806 001 Mar 25, 1994 Mar CAHN >A> + UCB 8MG;60MG N19806 001 Mar 25, 1994 Mar CAHN ACYCLOVIR CAPSULE; ORAL ACYCLOVIR >D> AB COPLEY PHARM 200MG N74914 001 Nov 26, 1997 Mar CAHN >A> AB TEVA PHARMS 200MG N74914 001 Nov 26, 1997 Mar CAHN TABLET; ORAL ACYCLOVIR >D> AB COPLEY PHARM 400MG N75021 001 Mar 18, 1998 Mar CAHN >D> AB 800MG N75021 002 Mar 18, 1998 Mar CAHN >A> AB TEVA PHARMS 400MG N75021 001 Mar 18, 1998 Mar CAHN >A> AB 800MG N75021 002 Mar 18, 1998 Mar CAHN AMANTADINE HYDROCHLORIDE SYRUP; ORAL AMANTADINE HCL >D> AA COPLEY PHARM 50MG/5ML N73115 001 Aug 23, 1991 Mar CAHN >A> AA TEVA PHARMS 50MG/5ML N73115 001 Aug 23, 1991 Mar CAHN AMINO ACIDS INJECTABLE; INJECTION AMINOSYN 7% >D> @ HOSPIRA 7% (7GM/100ML) N17673 002 Mar CMFD >A> 7% (7GM/100ML) N17673 002 Mar CMFD AMINOSYN 8.5% >D> @ HOSPIRA 8.5% (8.5GM/100ML) N17673 004 Mar CMFD >A> 8.5% (8.5GM/100ML) N17673 004 Mar CMFD AMIODARONE INJECTABLE; INTRAVENOUS AMIODARONE HCL >A> AP APOTEX 50MG/ML N77161 001 Apr 20, 2005 Mar NEWA AMIODARONE HYDROCHLORIDE INJECTABLE; INJECTION AMIODARONE HCL >D> AP AM PHARM PARTNERS 50MG/ML N75761 001 Oct 15, 2002 Mar CRLD >A> AP + 50MG/ML N75761 001 Oct 15, 2002 Mar CRLD >D> AP APOTEX 50MG/ML N76394 001 Apr 25, 2003 Mar CRLD >A> AP + 50MG/ML N76394 001 Apr 25, 2003 Mar CRLD >D> AP BEDFORD 50MG/ML N76018 001 Oct 15, 2002 Mar CRLD >A> AP + 50MG/ML N76018 001 Oct 15, 2002 Mar CRLD >D> AP BEDFORD LABS 50MG/ML N76299 001 Oct 24, 2002 Mar CRLD >A> AP + 50MG/ML N76299 001 Oct 24, 2002 Mar CRLD >D> AP BEN VENUE 50MG/ML N76088 001 Oct 15, 2002 Mar CRLD >A> AP + 50MG/ML N76088 001 Oct 15, 2002 Mar CRLD >D> AP BIONICHE (CANADA) 50MG/ML N76217 001 Oct 15, 2002 Mar CRLD >A> AP + 50MG/ML N76217 001 Oct 15, 2002 Mar CRLD >D> AP MAYNE PHARMA USA 50MG/ML N76108 001 Oct 15, 2002 Mar CRLD >A> AP + MAYNE PHARMA USA 50MG/ML N76108 001 Oct 15, 2002 Mar CRLD >D> AP SICOR PHARMS 50MG/ML N76163 001 Sep 05, 2003 Mar CRLD >A> AP + 50MG/ML N76163 001 Sep 05, 2003 Mar CRLD TABLET; ORAL AMIODARONE HCL >A> AB AUROSAL PHARMS 200MG N77069 001 Apr 08, 2005 Mar NEWA >A> AB 400MG N77069 002 Apr 08, 2005 Mar NEWA >D> AB COPLEY PHARM 200MG N74739 001 Nov 30, 1998 Mar CAHN >D> TARO 100MG N75424 002 Dec 18, 2002 Mar CTEC >A> AB 100MG N75424 002 Dec 18, 2002 Mar CTEC >A> AB TEVA PHARMS 200MG N74739 001 Nov 30, 1998 Mar CAHN PACERONE >A> AB UPSHER SMITH 100MG N75135 002 Apr 12, 2005 Mar NEWA ANAGRELIDE HYDROCHLORIDE CAPSULE; ORAL AGRYLIN >D> SHIRE EQ 0.5MG BASE N20333 001 Mar 14, 1997 Mar CFTG >A> AB EQ 0.5MG BASE N20333 001 Mar 14, 1997 Mar CFTG >D> + EQ 1MG BASE N20333 002 Mar 14, 1997 Mar CFTG >A> AB + EQ 1MG BASE N20333 002 Mar 14, 1997 Mar CFTG >A> ANAGRELIDE HCL >A> AB BARR EQ 0.5MG BASE N76530 001 Apr 18, 2005 Mar NEWA >A> AB EQ 1MG BASE N76530 002 Apr 18, 2005 Mar NEWA >A> AB EON EQ 0.5MG BASE N76683 001 Apr 18, 2005 Mar NEWA >A> AB EQ 1MG BASE N76683 002 Apr 18, 2005 Mar NEWA >A> AB IMPAX LABS EQ 0.5MG BASE N76910 001 Apr 18, 2005 Mar NEWA >A> AB EQ 1MG BASE N76910 002 Apr 18, 2005 Mar NEWA >A> AB IVAX PHARMS EQ 0.5MG BASE N76468 001 Apr 18, 2005 Mar NEWA >A> AB EQ 1MG BASE N76468 002 Apr 18, 2005 Mar NEWA >A> AB MYLAN EQ 0.5MG BASE N76811 001 Apr 18, 2005 Mar NEWA >A> AB EQ 1MG BASE N76811 002 Apr 18, 2005 Mar NEWA >A> AB ROXANE EQ 0.5MG BASE N76489 001 Apr 18, 2005 Mar NEWA >A> AB EQ 1MG BASE N76489 002 Apr 18, 2005 Mar NEWA >A> AB WATSON LABS EQ 0.5MG BASE N76417 001 Apr 18, 2005 Mar NEWA >A> AB EQ 1MG BASE N76417 002 Apr 18, 2005 Mar NEWA ATENOLOL TABLET; ORAL ATENOLOL >D> AB COPLEY PHARM 50MG N74120 001 Feb 24, 1995 Mar CAHN >D> AB 100MG N74120 002 Feb 24, 1995 Mar CAHN >D> MYLAN 25MG N73457 002 Apr 26, 1999 Mar CTEC >A> AB 25MG N73457 002 Apr 26, 1999 Mar CTEC >A> AB TEVA PHARMS 50MG N74120 001 Feb 24, 1995 Mar CAHN >A> AB 100MG N74120 002 Feb 24, 1995 Mar CAHN >D> BENZYL PENICILLOYL-POLYLYSINE >D> INJECTABLE; INJECTION >D> PRE-PEN >D> + HOLLISTER STIER 60UMOLAR N50114 001 Mar DISC >A> @ 60UMOLAR N50114 001 Mar DISC BETAMETHASONE DIPROPIONATE LOTION; TOPICAL BETAMETHASONE DIPROPIONATE >D> AB COPLEY PHARM EQ 0.05% BASE N71882 001 Jun 06, 1988 Mar CAHN >A> AB TEVA PHARMS EQ 0.05% BASE N71882 001 Jun 06, 1988 Mar CAHN BETAMETHASONE VALERATE LOTION; TOPICAL BETAMETHASONE VALERATE >D> AB COPLEY PHARM EQ 0.1% BASE N71883 001 Apr 22, 1988 Mar CAHN >A> AB TEVA PHARMS EQ 0.1% BASE N71883 001 Apr 22, 1988 Mar CAHN BISOPROLOL FUMARATE TABLET; ORAL BISOPROLOL FUMARATE >D> AB COPLEY PHARM 5MG N75644 001 Jun 26, 2001 Mar CAHN >D> AB COPLEY PHARM 10MG N75644 002 Jun 26, 2001 Mar CAHN >A> AB TEVA PHARMS 5MG N75644 001 Jun 26, 2001 Mar CAHN >A> AB 10MG N75644 002 Jun 26, 2001 Mar CAHN >A> BROMFENAC SODIUM >A> SOLUTION/DROPS; OPHTHALMIC >A> XIBROM >A> + ISTA PHARMS 0.09% N21664 001 Mar 24, 2005 Mar NEWA BROMOCRIPTINE MESYLATE CAPSULE; ORAL BROMOCRIPTINE MESYLATE >A> AB MYLAN EQ 5MG BASE N77226 001 Apr 04, 2005 Mar NEWA PARLODEL >D> + NOVARTIS EQ 5MG BASE N17962 002 Mar 01, 1982 Mar CTEC >A> AB + EQ 5MG BASE N17962 002 Mar 01, 1982 Mar CTEC CAPTOPRIL TABLET; ORAL CAPTOPRIL >D> AB COPLEY PHARM 12.5MG N74462 001 Feb 13, 1996 Mar CAHN >D> AB 25MG N74462 002 Feb 13, 1996 Mar CAHN >D> AB 50MG N74462 003 Feb 13, 1996 Mar CAHN >D> AB 100MG N74462 004 Feb 13, 1996 Mar CAHN >A> AB TEVA PHARMS 12.5MG N74462 001 Feb 13, 1996 Mar CAHN >A> AB 25MG N74462 002 Feb 13, 1996 Mar CAHN >A> AB 50MG N74462 003 Feb 13, 1996 Mar CAHN >A> AB 100MG N74462 004 Feb 13, 1996 Mar CAHN CARBAMAZEPINE SUSPENSION; ORAL CARBAMAZEPINE >D> AB TARO 100MG/5ML N75875 001 Dec 21, 2000 Mar DISC >A> @ 100MG/5ML N75875 001 Dec 21, 2000 Mar DISC CARBOPLATIN INJECTABLE; INJECTION CARBOPLATIN >A> AP EON 50MG/VIAL N76959 001 Mar 18, 2005 Mar NEWA >A> AP 150MG/VIAL N76959 002 Mar 18, 2005 Mar NEWA >A> AP 450MG/VIAL N76959 003 Mar 18, 2005 Mar NEWA CEFACLOR CAPSULE; ORAL >D> CECLOR >D> AB LILLY EQ 250MG BASE N50521 001 Mar DISC >A> @ EQ 250MG BASE N50521 001 Mar DISC >D> AB + EQ 500MG BASE N50521 002 Mar DISC >A> @ EQ 500MG BASE N50521 002 Mar DISC CEFACLOR >D> AB RANBAXY EQ 500MG BASE N64156 002 Aug 28, 1997 Mar CRLD >A> AB + EQ 500MG BASE N64156 002 Aug 28, 1997 Mar CRLD FOR SUSPENSION; ORAL CECLOR >D> AB + CEPH INTL EQ 375MG BASE/5ML N62206 004 Apr 20, 1988 Mar CRLD >A> AB EQ 375MG BASE/5ML N62206 004 Apr 20, 1988 Mar CRLD >D> AB LILLY EQ 125MG BASE/5ML N50522 001 Mar DISC >A> @ EQ 125MG BASE/5ML N50522 001 Mar DISC >D> AB + EQ 250MG BASE/5ML N50522 002 Mar DISC >A> @ EQ 250MG BASE/5ML N50522 002 Mar DISC CEFACLOR >D> AB RANBAXY EQ 375MG BASE/5ML N64155 001 Oct 02, 1997 Mar CRLD >A> AB + EQ 375MG BASE/5ML N64155 001 Oct 02, 1997 Mar CRLD CEFAZOLIN SODIUM INJECTABLE; INJECTION CEFAZOLIN SODIUM >D> AP AM PHARM PARTNERS EQ 500MG BASE/VIAL N64169 001 Aug 14, 1998 Mar CRLD >A> AP + EQ 500MG BASE/VIAL N64169 001 Aug 14, 1998 Mar CRLD >D> AP EQ 1GM BASE/VIAL N64169 002 Aug 14, 1998 Mar CRLD >A> AP + AM PHARM PARTNERS EQ 1GM BASE/VIAL N64169 002 Aug 14, 1998 Mar CRLD >D> AP EQ 10GM BASE/VIAL N64170 001 Mar 18, 1998 Mar CRLD >A> AP + EQ 10GM BASE/VIAL N64170 001 Mar 18, 1998 Mar CRLD CEPHALEXIN CAPSULE; ORAL CEPHALEXIN >D> AB APOTHECON EQ 250MG BASE N63186 001 Dec 30, 1994 Mar DISC >A> @ EQ 250MG BASE N63186 001 Dec 30, 1994 Mar DISC >D> AB EQ 500MG BASE N63186 002 Dec 30, 1994 Mar DISC >A> @ EQ 500MG BASE N63186 002 Dec 30, 1994 Mar DISC CHLORPHENIRAMINE POLISTIREX; CODEINE POLISTIREX SUSPENSION, EXTENDED RELEASE; ORAL CODEPREX >D> + CELLTECH PHARMS EQ 4MG MALEATE/5ML;EQ 20MG N21369 001 Jun 21, 2004 Mar CAHN >A> + UCB EQ 4MG MALEATE/5ML;EQ 20MG N21369 001 Jun 21, 2004 Mar CAHN CHLORPHENIRAMINE POLISTIREX; HYDROCODONE POLISTIREX SUSPENSION, EXTENDED RELEASE; ORAL TUSSIONEX >D> + CELLTECH PHARMS EQ 8MG MALEATE/5ML;EQ 10MG N19111 001 Dec 31, 1987 Mar CAHN BITARTRATE/5ML >A> + UCB EQ 8MG MALEATE/5ML;EQ 10MG N19111 001 Dec 31, 1987 Mar CAHN BITARTRATE/5ML CHOLESTYRAMINE POWDER; ORAL CHOLESTYRAMINE >D> AB COPLEY PHARM EQ 4GM RESIN/PACKET N74554 001 Oct 02, 1996 Mar CAHN >D> AB EQ 4GM RESIN/SCOOPFUL N74554 002 Oct 02, 1996 Mar CAHN >A> AB TEVA PHARMS EQ 4GM RESIN/PACKET N74554 001 Oct 02, 1996 Mar CAHN >A> AB EQ 4GM RESIN/SCOOPFUL N74554 002 Oct 02, 1996 Mar CAHN CHOLESTYRAMINE LIGHT >D> AB COPLEY PHARM EQ 4GM RESIN/PACKET N74555 001 Sep 30, 1998 Mar CAHN >D> AB EQ 4GM RESIN/SCOOPFUL N74555 002 Sep 30, 1998 Mar CAHN >A> AB TEVA PHARMS EQ 4GM RESIN/PACKET N74555 001 Sep 30, 1998 Mar CAHN >A> AB EQ 4GM RESIN/SCOOPFUL N74555 002 Sep 30, 1998 Mar CAHN CICLOPIROX CREAM; TOPICAL CICLOPIROX >A> AB TARO 0.77% N76790 001 Apr 12, 2005 Mar NEWA CIMETIDINE HYDROCHLORIDE SOLUTION; ORAL CIMETIDINE HCL >D> AA COPLEY PHARM EQ 300MG BASE/5ML N74859 001 Jul 09, 1998 Mar CAHN >A> AA TEVA PHARMS EQ 300MG BASE/5ML N74859 001 Jul 09, 1998 Mar CAHN CLEMASTINE FUMARATE SYRUP; ORAL CLEMASTINE FUMARATE >D> AA COPLEY PHARM EQ 0.5MG BASE/5ML N73095 001 Apr 21, 1992 Mar CAHN >A> AA TEVA PHARMS EQ 0.5MG BASE/5ML N73095 001 Apr 21, 1992 Mar CAHN CLINDAMYCIN PHOSPHATE INJECTABLE; INJECTION CLINDAMYCIN PHOSPHATE >D> @ HOSPIRA EQ 150MG BASE/ML N62943 001 Sep 29, 1988 Mar CMFD >A> AP EQ 150MG BASE/ML N62943 001 Sep 29, 1988 Mar CMFD CLOBETASOL PROPIONATE CREAM; TOPICAL CLOBETASOL PROPIONATE >D> AB1 COPLEY PHARM 0.05% N74087 001 Feb 16, 1994 Mar CAHN >A> AB1 TEVA PHARMS 0.05% N74087 001 Feb 16, 1994 Mar CAHN OINTMENT; TOPICAL CLOBETASOL PROPIONATE >D> AB COPLEY PHARM 0.05% N74089 001 Feb 16, 1994 Mar CAHN >A> AB TEVA PHARMS 0.05% N74089 001 Feb 16, 1994 Mar CAHN CROMOLYN SODIUM SOLUTION, CONCENTRATE; ORAL GASTROCROM >D> + CELLTECH PHARMS 100MG/5ML N20479 001 Feb 29, 1996 Mar CAHN >A> + UCB 100MG/5ML N20479 001 Feb 29, 1996 Mar CAHN CYCLOSPORINE CAPSULE; ORAL CYCLOSPORINE >A> AB1 IVAX PHARMS 25MG N65110 003 Mar 29, 2005 Mar NEWA >A> AB1 50MG N65110 001 Mar 29, 2005 Mar NEWA >A> AB1 100MG N65110 002 Mar 29, 2005 Mar NEWA GENGRAF >D> BX ABBOTT 50MG N65003 002 May 12, 2000 Mar CTEC >A> AB1 50MG N65003 002 May 12, 2000 Mar CTEC SOLUTION; ORAL CYCLOSPORINE >A> AB1 IVAX PHARMS 100MG/ML N65078 001 Mar 25, 2005 Mar NEWA >D> DESIRUDIN >D> INJECTABLE; SUBCUTANEOUS >D> IPRIVASK >D> + CANYON 15MG/VIAL N21271 001 Apr 04, 2003 Mar CAIN >A> DESIRUDIN RECOMBINANT >A> INJECTABLE; SUBCUTANEOUS >A> IPRIVASK >A> + CANYON 15MG/VIAL N21271 001 Apr 04, 2003 Mar CAIN DESLORATADINE; PSEUDOEPHEDRINE SULFATE >A> TABLET, EXTENDED RELEASE; ORAL >A> CLARINEX D 24 HOUR >A> + SCHERING 5MG;240MG N21605 001 Mar 03, 2005 Mar NEWA DESONIDE CREAM; TOPICAL DESONIDE >D> AB COPLEY PHARM 0.05% N74027 001 Sep 28, 1992 Mar CAHN >A> AB TEVA PHARMS 0.05% N74027 001 Sep 28, 1992 Mar CAHN DEXAMETHASONE TABLET; ORAL DEXAMETHASONE >D> + PAR PHARM 0.25MG N88149 001 Apr 28, 1983 Mar CRLD >A> 0.25MG N88149 001 Apr 28, 1983 Mar CRLD >D> BP + ROXANE 1.5MG N84610 001 Mar CRLD >A> BP 1.5MG N84610 001 Mar CRLD DEXTROSE INJECTABLE; INJECTION DEXTROSE 50% IN PLASTIC CONTAINER >D> @ HOSPIRA 500MG/ML N19445 001 Jun 03, 1986 Mar CMFD >A> AP 500MG/ML N19445 001 Jun 03, 1986 Mar CMFD DICLOFENAC SODIUM TABLET, DELAYED RELEASE; ORAL DICLOFENAC SODIUM >D> AB COPLEY PHARM 25MG N74459 001 Jun 25, 1997 Mar CAHN >D> AB 50MG N74459 002 Jun 25, 1997 Mar CAHN >D> AB 75MG N74459 003 Jun 25, 1997 Mar CAHN >A> AB TEVA PHARMS 25MG N74459 001 Jun 25, 1997 Mar CAHN >A> AB 50MG N74459 002 Jun 25, 1997 Mar CAHN >A> AB 75MG N74459 003 Jun 25, 1997 Mar CAHN DICYCLOMINE HYDROCHLORIDE SYRUP; ORAL BENTYL >D> + AXCAN SCANDIPHARM 10MG/5ML N07961 002 Oct 15, 1984 Mar CTEC >A> AA + AXCAN SCANDIPHARM 10MG/5ML N07961 002 Oct 15, 1984 Mar CTEC >A> DICYCLOMINE HCL >A> AA MIKART 10MG/5ML N40169 001 Mar 24, 2005 Mar NEWA DILTIAZEM HYDROCHLORIDE INJECTABLE; INJECTION CARDIZEM >D> AP + BIOVAIL 5MG/ML N20027 001 Oct 24, 1991 Mar CAHN >D> + 25MG/VIAL N20027 003 Aug 18, 1995 Mar CAHN >A> AP + BIOVAIL LABS INTL 5MG/ML N20027 001 Oct 24, 1991 Mar CAHN >A> + 25MG/VIAL N20027 003 Aug 18, 1995 Mar CAHN TABLET, EXTENDED RELEASE; ORAL CARDIZEM LA >D> BIOVAIL 120MG N21392 001 Feb 06, 2003 Mar CAHN >D> 180MG N21392 002 Feb 06, 2003 Mar CAHN >D> 240MG N21392 003 Feb 06, 2003 Mar CAHN >D> 300MG N21392 004 Feb 06, 2003 Mar CAHN >D> 360MG N21392 005 Feb 06, 2003 Mar CAHN >D> + 420MG N21392 006 Feb 06, 2003 Mar CAHN >A> BIOVAIL LABS INTL 120MG N21392 001 Feb 06, 2003 Mar CAHN >A> 180MG N21392 002 Feb 06, 2003 Mar CAHN >A> 240MG N21392 003 Feb 06, 2003 Mar CAHN >A> 300MG N21392 004 Feb 06, 2003 Mar CAHN >A> 360MG N21392 005 Feb 06, 2003 Mar CAHN >A> + 420MG N21392 006 Feb 06, 2003 Mar CAHN TABLET; ORAL CARDIZEM >D> AB BIOVAIL 30MG N18602 001 Nov 05, 1982 Mar CAHN >D> AB 60MG N18602 002 Nov 05, 1982 Mar CAHN >D> AB 90MG N18602 003 Dec 08, 1986 Mar CAHN >D> AB + 120MG N18602 004 Dec 08, 1986 Mar CAHN >A> AB BIOVAIL LABS INTL 30MG N18602 001 Nov 05, 1982 Mar CAHN >A> AB 60MG N18602 002 Nov 05, 1982 Mar CAHN >A> AB 90MG N18602 003 Dec 08, 1986 Mar CAHN >A> AB + 120MG N18602 004 Dec 08, 1986 Mar CAHN DILTIAZEM HCL >D> AB COPLEY PHARM 30MG N74067 001 Nov 05, 1992 Mar CAHN >D> AB 60MG N74067 002 Nov 05, 1992 Mar CAHN >D> AB 90MG N74067 003 Nov 05, 1992 Mar CAHN >D> AB 120MG N74067 004 Nov 05, 1992 Mar CAHN >A> AB TEVA PHARMS 30MG N74067 001 Nov 05, 1992 Mar CAHN >A> AB 60MG N74067 002 Nov 05, 1992 Mar CAHN >A> AB 90MG N74067 003 Nov 05, 1992 Mar CAHN >A> AB 120MG N74067 004 Nov 05, 1992 Mar CAHN DOXEPIN HYDROCHLORIDE CONCENTRATE; ORAL DOXEPIN HCL >D> AA COPLEY PHARM EQ 10MG BASE/ML N71609 001 Nov 09, 1987 Mar CAHN >A> AA TEVA PHARMS EQ 10MG BASE/ML N71609 001 Nov 09, 1987 Mar CAHN DOXYCYCLINE CAPSULE; ORAL DOXYCYCLINE >A> AB PAR PHARM EQ 75MG BASE N65055 004 Apr 18, 2005 Mar NEWA >D> + RANBAXY EQ 75MG BASE N65053 003 Sep 10, 2003 Mar CTEC >A> AB EQ 75MG BASE N65053 003 Sep 10, 2003 Mar CTEC ENALAPRIL MALEATE TABLET; ORAL VASOTEC >D> AB BIOVAIL 2.5MG N18998 005 Jul 26, 1988 Mar CAHN >D> AB 5MG N18998 001 Dec 24, 1985 Mar CAHN >D> AB 10MG N18998 002 Dec 24, 1985 Mar CAHN >D> AB + 20MG N18998 003 Dec 24, 1985 Mar CAHN >A> AB BIOVAIL LABS INTL 2.5MG N18998 005 Jul 26, 1988 Mar CAHN >A> AB 5MG N18998 001 Dec 24, 1985 Mar CAHN >A> AB 10MG N18998 002 Dec 24, 1985 Mar CAHN >A> AB + 20MG N18998 003 Dec 24, 1985 Mar CAHN ENALAPRIL MALEATE; HYDROCHLOROTHIAZIDE TABLET; ORAL VASERETIC >D> AB BIOVAIL 5MG;12.5MG N19221 003 Jul 12, 1995 Mar CAHN >D> AB + 10MG;25MG N19221 001 Oct 31, 1986 Mar CAHN >A> AB BIOVAIL LABS INTL 5MG;12.5MG N19221 003 Jul 12, 1995 Mar CAHN >A> AB + 10MG;25MG N19221 001 Oct 31, 1986 Mar CAHN ENALAPRILAT INJECTABLE; INJECTION VASOTEC >D> AP + BIOVAIL 1.25MG/ML N19309 001 Feb 09, 1988 Mar CAHN >A> AP + BIOVAIL LABS INTL 1.25MG/ML N19309 001 Feb 09, 1988 Mar CAHN >A> ENTECAVIR >A> SOLUTION; ORAL >A> BARACLUDE >A> + BRISTOL MYERS 0.05MG/ML N21798 001 Mar 29, 2005 Mar NEWA >A> TABLET; ORAL >A> BARACLUDE >A> BRISTOL MYERS 0.5MG N21797 001 Mar 29, 2005 Mar NEWA >A> + 1MG N21797 002 Mar 29, 2005 Mar NEWA >A> ESOMEPRAZOLE SODIUM >A> INJECTABLE; INTRAVENOUS >A> NEXIUM IV >A> + ASTRAZENECA 20MG/VIAL N21689 001 Mar 31, 2005 Mar NEWA >A> + 40MG/VIAL N21689 002 Mar 31, 2005 Mar NEWA ESTROGENS, CONJUGATED SYNTHETIC B >D> TABLET; ORAL >D> ENJUVIA >A> @ DURAMED 0.3MG N21443 001 Dec 20, 2004 Mar DISC >A> @ 0.45MG N21443 002 Dec 20, 2004 Mar DISC ETHINYL ESTRADIOL; NORETHINDRONE TABLET; ORAL-21 NORETHINDRONE AND ETHINYL ESTRADIOL (7/14) >D> AB + WATSON LABS 0.035MG,0.035MG;0.5MG,1MG N71041 001 Sep 24, 1991 Mar CTEC >A> + 0.035MG,0.035MG;0.5MG,1MG N71041 001 Sep 24, 1991 Mar CTEC NORTREL 7/7/7 >D> AB BARR 0.035MG,0.035MG,0.035MG;0.5MG,0.75M N75478 001 Aug 30, 2002 Mar CTEC G,1MG >A> 0.035MG,0.035MG,0.035MG;0.5MG,0.75M N75478 001 Aug 30, 2002 Mar CTEC G,1MG TABLET; ORAL-28 NORETHINDRONE AND ETHINYL ESTRADIOL (7/14) >D> AB WATSON LABS 0.035MG,0.035MG;0.5MG,1MG N71042 001 Sep 24, 1991 Mar CTEC >A> 0.035MG,0.035MG;0.5MG,1MG N71042 001 Sep 24, 1991 Mar CTEC ORTHO-NOVUM 10/11-28 >D> AB ORTHO MCNEIL 0.035MG,0.035MG;0.5MG,1MG N18354 002 Jan 11, 1982 Mar CRLD >A> AB + 0.035MG,0.035MG;0.5MG,1MG N18354 002 Jan 11, 1982 Mar CRLD OVCON-35 >D> AB + WARNER CHILCOTT 0.035MG;0.4MG N17716 001 Mar CRLD >A> AB 0.035MG;0.4MG N17716 001 Mar CRLD ETHOSUXIMIDE SYRUP; ORAL ETHOSUXIMIDE >D> AA COPLEY PHARM 250MG/5ML N81306 001 Jul 30, 1993 Mar CAHN >A> AA TEVA PHARMS 250MG/5ML N81306 001 Jul 30, 1993 Mar CAHN FEXOFENADINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE TABLET, EXTENDED RELEASE; ORAL ALLEGRA-D 12 HOUR >D> + AVENTIS PHARMS 60MG;120MG N20786 001 Dec 24, 1997 Mar CFTG >A> AB + 60MG;120MG N20786 001 Dec 24, 1997 Mar CFTG >A> FEXOFENADINE HCL AND PSEUDOEPHEDRINE HCL >A> AB BARR 60MG;120MG N76236 001 Apr 14, 2005 Mar NEWA FLUCONAZOLE INJECTABLE; INJECTION FLUCONAZOLE IN DEXTROSE 5% IN PLASTIC CONTAINER >A> AP APOTEX 200MG/100ML N76888 001 Mar 25, 2005 Mar NEWA FLUCONAZOLE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER >A> AP APOTEX 200MG/100ML N76889 001 Mar 25, 2005 Mar NEWA FLUOCINONIDE SOLUTION; TOPICAL FLUOCINONIDE >D> AT COPLEY PHARM 0.05% N72522 001 Sep 28, 1990 Mar CAHN >A> AT TEVA PHARMS 0.05% N72522 001 Sep 28, 1990 Mar CAHN FLUPHENAZINE HYDROCHLORIDE CONCENTRATE; ORAL FLUPHENAZINE HCL >D> AA COPLEY PHARM 5MG/ML N73058 001 Aug 30, 1991 Mar CAHN >A> AA TEVA PHARMS 5MG/ML N73058 001 Aug 30, 1991 Mar CAHN ELIXIR; ORAL FLUPHENAZINE HCL >D> AA COPLEY PHARM 2.5MG/5ML N81310 001 Apr 29, 1993 Mar CAHN >A> AA TEVA PHARMS 2.5MG/5ML N81310 001 Apr 29, 1993 Mar CAHN FLUTICASONE PROPIONATE >A> LOTION; TOPICAL >A> CUTIVATE >A> + GLAXOSMITHKLINE 0.05% N21152 001 Mar 31, 2005 Mar NEWA FOSINOPRIL SODIUM TABLET; ORAL FOSINOPRIL SODIUM >A> AB INVAGEN PHARMS 10MG N77222 001 Apr 20, 2005 Mar NEWA >A> AB 20MG N77222 002 Apr 20, 2005 Mar NEWA >A> AB 40MG N77222 003 Apr 20, 2005 Mar NEWA GABAPENTIN CAPSULE; ORAL GABAPENTIN >A> AB APOTEX 100MG N75360 001 Apr 06, 2005 Mar NEWA >A> AB 300MG N75360 002 Apr 06, 2005 Mar NEWA >A> AB 400MG N75360 003 Apr 06, 2005 Mar NEWA >A> AB EON 100MG N75539 001 Apr 06, 2005 Mar NEWA >A> AB 300MG N75539 002 Apr 06, 2005 Mar NEWA >A> AB 400MG N75539 003 Apr 06, 2005 Mar NEWA >A> AB IVAX PHARMS 100MG N75477 001 Mar 23, 2005 Mar NEWA >A> AB 300MG N75477 002 Mar 23, 2005 Mar NEWA >A> AB 400MG N75477 003 Mar 23, 2005 Mar NEWA GATIFLOXACIN INJECTABLE; INJECTION TEQUIN >D> + BRISTOL MYERS EQ 2MG /ML(200MG/100ML) N21062 001 Dec 17, 1999 Mar CPOT >D> + EQ 2MG /ML(400MG/200ML) N21062 002 Dec 17, 1999 Mar CPOT >D> + EQ 10MG /ML(400MG) N21062 004 Dec 17, 1999 Mar CPOT >A> + 400MG/40ML(10MG/ML) N21062 004 Dec 17, 1999 Mar CPOT TEQUIN IN DEXTROSE 5% IN PLASTIC CONTAINER >A> + BRISTOL MYERS 200MG/100ML(2MG/ML) N21062 001 Dec 17, 1999 Mar CPOT >A> + 400MG/200ML(2MG/ML) N21062 002 Dec 17, 1999 Mar CPOT GUANABENZ ACETATE TABLET; ORAL GUANABENZ ACETATE >D> AB COPLEY PHARM EQ 4MG BASE N74267 001 Jun 01, 1994 Mar CAHN >D> AB EQ 8MG BASE N74267 002 Jun 01, 1994 Mar CAHN >A> AB TEVA PHARMS EQ 4MG BASE N74267 001 Jun 01, 1994 Mar CAHN >A> AB EQ 8MG BASE N74267 002 Jun 01, 1994 Mar CAHN HALOPERIDOL LACTATE CONCENTRATE; ORAL HALOPERIDOL >D> AA + COPLEY PHARM EQ 2MG BASE/ML N71617 001 Dec 01, 1988 Mar CAHN >A> AA + TEVA PHARMS EQ 2MG BASE/ML N71617 001 Dec 01, 1988 Mar CAHN HYDROCHLOROTHIAZIDE; IRBESARTAN TABLET; ORAL AVALIDE >D> + SANOFI 12.5MG;300MG N20758 003 Aug 31, 1998 Mar CRLD >A> 12.5MG;300MG N20758 003 Aug 31, 1998 Mar CRLD >A> + 25MG;300MG N20758 004 Mar 15, 2005 Mar NEWA HYDROCHLOROTHIAZIDE; QUINAPRIL HYDROCHLORIDE TABLET; ORAL >A> QUINAPRIL HCL AND HYDROCHLOROTHIAZIDE >A> AB MYLAN 12.5MG;EQ 10MG BASE N77093 001 Mar 28, 2005 Mar NEWA >A> AB 12.5MG;EQ 20MG BASE N77093 002 Mar 28, 2005 Mar NEWA >A> AB 25MG;EQ 20MG BASE N77093 003 Mar 28, 2005 Mar NEWA HYDROCHLOROTHIAZIDE; VALSARTAN TABLET; ORAL DIOVAN HCT >D> + NOVARTIS 12.5MG;160MG N20818 002 Mar 06, 1998 Mar CRLD >A> 12.5MG;160MG N20818 002 Mar 06, 1998 Mar CRLD >D> 25MG;160MG N20818 003 Jan 17, 2002 Mar CRLD >A> + 25MG;160MG N20818 003 Jan 17, 2002 Mar CRLD HYDROCORTISONE ENEMA; RECTAL HYDROCORTISONE >D> AB COPLEY PHARM 100MG/60ML N74171 001 May 27, 1994 Mar CAHN >A> AB TEVA PHARMS 100MG/60ML N74171 001 May 27, 1994 Mar CAHN HYDROCORTISONE VALERATE CREAM; TOPICAL HYDROCORTISONE VALERATE >D> AB COPLEY PHARM 0.2% N74489 001 Aug 12, 1998 Mar CAHN >A> AB TEVA PHARMS 0.2% N74489 001 Aug 12, 1998 Mar CAHN HYDROXYCHLOROQUINE SULFATE TABLET; ORAL HYDROXYCHLOROQUINE SULFATE >D> AB COPLEY PHARM 200MG N40081 001 Sep 30, 1994 Mar CAHN >A> AB TEVA PHARMS 200MG N40081 001 Sep 30, 1994 Mar CAHN HYDROXYPROGESTERONE CAPROATE INJECTABLE; INJECTION HYDROXYPROGESTERONE CAPROATE >D> @ STERIS 125MG/ML N17439 001 Mar CAHN >D> @ 250MG/ML N17439 002 Mar CAHN >A> @ WATSON LABS 125MG/ML N17439 001 Mar CAHN >A> @ 250MG/ML N17439 002 Mar CAHN IBANDRONATE SODIUM TABLET; ORAL BONIVA >A> ROCHE EQ 150MG BASE N21455 002 Mar 24, 2005 Mar NEWA IRON SUCROSE INJECTABLE; INTRAVENOUS VENOFER >D> + LUITPOLD EQ 20MG BASE/ML N21135 001 Nov 06, 2000 Mar CPOT >A> + EQ 100MG BASE/5ML(EQ 20MG BASE/ML) N21135 001 Nov 06, 2000 Mar CPOT >A> EQ 50MG BASE/2.5ML(EQ 20MG N21135 002 Mar 20, 2005 Mar NEWA >A> EQ 75MG BASE/3.75ML(EQ 20MG N21135 003 Mar 29, 2005 Mar NEWA ISRADIPINE TABLET, EXTENDED RELEASE; ORAL DYNACIRC CR >D> + RELIANT PHARMS 5MG N20336 001 Jun 01, 1994 Mar CRLD >A> 5MG N20336 001 Jun 01, 1994 Mar CRLD KETOCONAZOLE SHAMPOO; TOPICAL KETOCONAZOLE >A> AB QLT USA 2% N76942 001 Apr 11, 2005 Mar NEWA LACTULOSE SOLUTION; ORAL EVALOSE >D> AA COPLEY PHARM 10GM/15ML N73497 001 May 28, 1993 Mar CAHN >A> AA TEVA PHARMS 10GM/15ML N73497 001 May 28, 1993 Mar CAHN SOLUTION; ORAL, RECTAL HEPTALAC >D> AA COPLEY PHARM 10GM/15ML N73504 001 May 28, 1993 Mar CAHN >A> AA TEVA PHARMS 10GM/15ML N73504 001 May 28, 1993 Mar CAHN >D> LEPIRUDIN >D> INJECTABLE; INJECTION >D> REFLUDAN >D> + BERLEX 50MG/VIAL N20807 001 Mar 06, 1998 Mar CAIN >A> LEPIRUDIN RECOMBINANT >A> INJECTABLE; INJECTION >A> REFLUDAN >A> + BERLEX 50MG/VIAL N20807 001 Mar 06, 1998 Mar CAIN LEVALBUTEROL TARTRATE >A> AEROSOL, METERED; INHALATION >A> XOPENEX HFA >A> + SEPRACOR EQ 0.045MG BASE/INH N21730 001 Mar 11, 2005 Mar NEWA LEVOFLOXACIN TABLET; ORAL LEVAQUIN >D> AB ORTHO MCNEIL 250MG N20634 001 Dec 20, 1996 Mar CTEC >A> 250MG N20634 001 Dec 20, 1996 Mar CTEC >D> AB 500MG N20634 002 Dec 20, 1996 Mar CTEC >A> 500MG N20634 002 Dec 20, 1996 Mar CTEC LIDOCAINE HYDROCHLORIDE JELLY; TOPICAL LIDOCAINE HCL >D> AT COPLEY PHARM 2% N81318 001 Apr 29, 1993 Mar CAHN >A> AT TEVA PHARMS 2% N81318 001 Apr 29, 1993 Mar CAHN MEBENDAZOLE TABLET, CHEWABLE; ORAL MEBENDAZOLE >D> AB COPLEY PHARM 100MG N73580 001 Jan 04, 1995 Mar CAHN >A> AB TEVA PHARMS 100MG N73580 001 Jan 04, 1995 Mar CAHN MEGESTROL ACETATE SUSPENSION; ORAL MEGESTROL ACETATE >D> AB COPLEY PHARM 40MG/ML N75681 001 May 05, 2003 Mar CAHN >A> AB TEVA PHARMS 40MG/ML N75681 001 May 05, 2003 Mar CAHN METAPROTERENOL SULFATE SYRUP; ORAL METAPROTERENOL SULFATE >D> @ COPLEY PHARM 10MG/5ML N73034 001 Aug 30, 1991 Mar CAHN >A> @ TEVA PHARMS 10MG/5ML N73034 001 Aug 30, 1991 Mar CAHN METFORMIN HYDROCHLORIDE TABLET, EXTENDED RELEASE; ORAL METFORMIN HCL >A> AB ANDRX PHARMS 750MG N76869 001 Apr 12, 2005 Mar NEWA >A> AB PUREPAC PHARM 750MG N76878 001 Apr 13, 2005 Mar NEWA >A> AB TEVA 750MG N76864 001 Apr 12, 2005 Mar NEWA >A> AB ZYDUS PHARMS USA 500MG N77060 001 Apr 20, 2005 Mar NEWA TABLET; ORAL METFORMIN HCL >A> AB ZYDUS PHARMS USA 500MG N77064 001 Apr 18, 2005 Mar NEWA >A> AB 850MG N77064 002 Apr 18, 2005 Mar NEWA >A> AB 1GM N77064 003 Apr 18, 2005 Mar NEWA METHAZOLAMIDE TABLET; ORAL METHAZOLAMIDE >D> AB COPLEY PHARM 25MG N40001 001 Jun 30, 1993 Mar CAHN >D> AB 50MG N40001 002 Jun 30, 1993 Mar CAHN >A> AB TEVA PHARMS 25MG N40001 001 Jun 30, 1993 Mar CAHN >A> AB 50MG N40001 002 Jun 30, 1993 Mar CAHN METOLAZONE TABLET; ORAL ZAROXOLYN >D> AB CELLTECH PHARMS 2.5MG N17386 001 Mar CAHN >D> AB + 5MG N17386 002 Mar CAHN >D> AB + 10MG N17386 003 Mar CAHN >A> AB UCB 2.5MG N17386 001 Mar CAHN >A> AB + 5MG N17386 002 Mar CAHN >A> AB + 10MG N17386 003 Mar CAHN METOPROLOL TARTRATE TABLET; ORAL METOPROLOL TARTRATE >D> AB COPLEY PHARM 50MG N74333 001 Jan 27, 1994 Mar CAHN >D> AB 100MG N74333 002 Jan 27, 1994 Mar CAHN >A> AB TEVA PHARMS 50MG N74333 001 Jan 27, 1994 Mar CAHN >A> AB 100MG N74333 002 Jan 27, 1994 Mar CAHN >A> MICAFUNGIN SODIUM >A> INJECTABLE; IV (INFUSION) >A> MYCAMINE >A> + ASTELLAS 50MG/VIAL N21506 002 Mar 16, 2005 Mar NEWA MIDAZOLAM HYDROCHLORIDE INJECTABLE; INJECTION MIDAZOLAM HCL >D> @ HOSPIRA EQ 1MG BASE/ML N75293 001 Jun 20, 2000 Mar CMFD >A> AP EQ 1MG BASE/ML N75293 001 Jun 20, 2000 Mar CMFD >D> @ EQ 5MG BASE/ML N75293 002 Jun 20, 2000 Mar CMFD >A> AP EQ 5MG BASE/ML N75293 002 Jun 20, 2000 Mar CMFD MOMETASONE FUROATE CREAM; TOPICAL MOMETASONE FUROATE >A> AB ALTANA 0.1% N76171 001 Apr 08, 2005 Mar NEWA LOTION; TOPICAL ELOCON >D> + SCHERING 0.1% N19796 001 Mar 30, 1989 Mar CFTG >A> AB + 0.1% N19796 001 Mar 30, 1989 Mar CFTG >A> MOMETASONE FUROATE >A> AB AGIS INDS 0.1% N77180 001 Apr 06, 2005 Mar NEWA OINTMENT; TOPICAL MOMETASONE FUROATE >A> AB ALTANA 0.1% N77061 001 Mar 28, 2005 Mar NEWA >A> POWDER; INHALATION >A> ASMANEX TWISTHALER >A> + SCHERING 0.22MG/INH N21067 001 Mar 30, 2005 Mar NEWA MOMETASONE FUROATE MONOHYDRATE SPRAY, METERED; NASAL NASONEX >D> + SCHERING PLOUGH EQ 0.05MG BASE/SPRAY N20762 001 Oct 01, 1997 Mar CAHN >A> + SHIRE EQ 0.05MG BASE/SPRAY N20762 001 Oct 01, 1997 Mar CAHN MORPHINE SULFATE CAPSULE, EXTENDED RELEASE; ORAL AVINZA >D> BX + LIGAND 30MG N21260 001 Mar 20, 2002 Mar CRLD >A> BX LIGAND 30MG N21260 001 Mar 20, 2002 Mar CRLD >D> BX + 60MG N21260 002 Mar 20, 2002 Mar CRLD >A> BX 60MG N21260 002 Mar 20, 2002 Mar CRLD >D> + 90MG N21260 003 Mar 20, 2002 Mar CRLD >A> 90MG N21260 003 Mar 20, 2002 Mar CRLD KADIAN >D> + ALPHARMA US 20MG N20616 001 Jul 03, 1996 Mar CRLD >A> 20MG N20616 001 Jul 03, 1996 Mar CRLD >D> BX + 30MG N20616 004 Mar 09, 2001 Mar CRLD >A> BX 30MG N20616 004 Mar 09, 2001 Mar CRLD >D> + 50MG N20616 002 Jul 03, 1996 Mar CRLD >A> 50MG N20616 002 Jul 03, 1996 Mar CRLD >D> BX + 60MG N20616 005 Mar 09, 2001 Mar CRLD >A> BX 60MG N20616 005 Mar 09, 2001 Mar CRLD NADOLOL TABLET; ORAL NADOLOL >D> AB COPLEY PHARM 80MG N74368 001 Aug 31, 1994 Mar CAHN >D> AB 120MG N74368 002 Aug 31, 1994 Mar CAHN >D> AB 160MG N74368 003 Aug 31, 1994 Mar CAHN >A> AB TEVA PHARMS 80MG N74368 001 Aug 31, 1994 Mar CAHN >A> AB 120MG N74368 002 Aug 31, 1994 Mar CAHN >A> AB 160MG N74368 003 Aug 31, 1994 Mar CAHN NALOXONE HYDROCHLORIDE INJECTABLE; INJECTION NALOXONE HCL >D> @ HOSPIRA 0.4MG/ML N70172 001 Sep 24, 1986 Mar CMFD >A> AP 0.4MG/ML N70172 001 Sep 24, 1986 Mar CMFD NAPROXEN TABLET; ORAL NAPROXEN >D> AB COPLEY PHARM 250MG N74207 001 Dec 21, 1993 Mar CAHN >D> AB 375MG N74207 002 Dec 21, 1993 Mar CAHN >D> AB 500MG N74207 003 Dec 21, 1993 Mar CAHN >A> AB TEVA PHARMS 250MG N74207 001 Dec 21, 1993 Mar CAHN >A> AB 375MG N74207 002 Dec 21, 1993 Mar CAHN >A> AB 500MG N74207 003 Dec 21, 1993 Mar CAHN NAPROXEN SODIUM TABLET; ORAL NAPROXEN SODIUM >D> AB COPLEY PHARM EQ 250MG BASE N74289 001 Jan 27, 1994 Mar CAHN >D> AB EQ 500MG BASE N74289 002 Jan 27, 1994 Mar CAHN >A> AB TEVA PHARMS EQ 250MG BASE N74289 001 Jan 27, 1994 Mar CAHN >A> AB EQ 500MG BASE N74289 002 Jan 27, 1994 Mar CAHN NIACIN TABLET, EXTENDED RELEASE; ORAL >A> NIACIN >A> AB BARR 1GM N76250 001 Apr 14, 2005 Mar NEWA NIASPAN >D> + KOS 1GM N20381 004 Jul 28, 1997 Mar CFTG >A> AB + 1GM N20381 004 Jul 28, 1997 Mar CFTG NICARDIPINE HYDROCHLORIDE INJECTABLE; INJECTION CARDENE >A> + ESP PHARMA 2.5MG/ML N19734 001 Jan 30, 1992 Mar CAHN >D> + ROCHE PALO 2.5MG/ML N19734 001 Jan 30, 1992 Mar CAHN NITROFURANTOIN; NITROFURANTOIN, MACROCRYSTALLINE CAPSULE; ORAL NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS) >A> AB EON 75MG;25MG N77066 001 Apr 05, 2005 Mar NEWA >A> AB RANBAXY 75MG;25MG N76951 001 Mar 30, 2005 Mar NEWA OCTREOTIDE ACETATE INJECTABLE; INJECTION >A> OCTREOTIDE ACETATE >A> AP BEDFORD EQ 0.2MG BASE/ML N76330 001 Apr 08, 2005 Mar NEWA >A> AP EQ 1MG BASE/ML N76330 002 Apr 08, 2005 Mar NEWA >A> OCTREOTIDE ACETATE (PRESERVATIVE FREE) >A> AP BEDFORD EQ 0.05MG BASE/ML N76313 001 Mar 28, 2005 Mar NEWA >A> AP EQ 0.1MG BASE/ML N76313 003 Mar 28, 2005 Mar NEWA >A> AP EQ 0.5MG BASE/ML N76313 002 Mar 28, 2005 Mar NEWA SANDOSTATIN >D> + NOVARTIS EQ 0.05MG BASE/ML N19667 001 Oct 21, 1988 Mar CFTG >A> AP + EQ 0.05MG BASE/ML N19667 001 Oct 21, 1988 Mar CFTG >D> + EQ 0.1MG BASE/ML N19667 002 Oct 21, 1988 Mar CFTG >A> AP + EQ 0.1MG BASE/ML N19667 002 Oct 21, 1988 Mar CFTG >D> + EQ 0.2MG BASE/ML N19667 004 Jun 12, 1991 Mar CFTG >A> AP + EQ 0.2MG BASE/ML N19667 004 Jun 12, 1991 Mar CFTG >D> + EQ 0.5MG BASE/ML N19667 003 Oct 21, 1988 Mar CFTG >A> AP + EQ 0.5MG BASE/ML N19667 003 Oct 21, 1988 Mar CFTG >D> + EQ 1MG BASE/ML N19667 005 Jun 12, 1991 Mar CFTG >A> AP + EQ 1MG BASE/ML N19667 005 Jun 12, 1991 Mar CFTG OLSALAZINE SODIUM CAPSULE; ORAL DIPENTUM >D> + CELLTECH PHARMS 250MG N19715 001 Jul 31, 1990 Mar CAHN >A> + UCB 250MG N19715 001 Jul 31, 1990 Mar CAHN OMEPRAZOLE CAPSULE, DELAYED REL PELLETS; ORAL PRILOSEC >D> AB + ASTRAZENECA 40MG N19810 002 Jan 15, 1998 Mar CTEC >A> 40MG N19810 002 Jan 15, 1998 Mar CTEC OXALIPLATIN INJECTABLE; IV (INFUSION) ELOXATIN >D> SANOFI 50MG/VIAL N21492 001 Aug 09, 2002 Mar CRLD >A> + 50MG/VIAL N21492 001 Aug 09, 2002 Mar CRLD PEMOLINE TABLET, CHEWABLE; ORAL PEMOLINE >D> AB COPLEY PHARM 37.5MG N75555 001 Feb 18, 2000 Mar CAHN >A> AB TEVA PHARMS 37.5MG N75555 001 Feb 18, 2000 Mar CAHN TABLET; ORAL PEMOLINE >D> AB COPLEY PHARM 18.75MG N75030 003 Feb 22, 2000 Mar CAHN >D> AB 37.5MG N75030 001 Jan 29, 1999 Mar CAHN >D> AB 75MG N75030 002 Jan 29, 1999 Mar CAHN >A> AB TEVA PHARMS 18.75MG N75030 003 Feb 22, 2000 Mar CAHN >A> AB 37.5MG N75030 001 Jan 29, 1999 Mar CAHN >A> AB 75MG N75030 002 Jan 29, 1999 Mar CAHN PHENTERMINE HYDROCHLORIDE TABLET; ORAL PHENTERMINE HCL >A> AA LANNETT 37.5MG N40555 001 Apr 15, 2005 Mar NEWA PHENTERMINE RESIN COMPLEX CAPSULE, EXTENDED RELEASE; ORAL IONAMIN >D> CELLTECH PHARMS EQ 15MG BASE N11613 004 Mar CAHN >D> + EQ 30MG BASE N11613 002 Mar CAHN >A> UCB EQ 15MG BASE N11613 004 Mar CAHN >A> + EQ 30MG BASE N11613 002 Mar CAHN PHENYTOIN SODIUM INJECTABLE; INJECTION PHENYTOIN >D> + ELKINS SINN 50MG/ML N84307 001 Mar CTEC >A> AP + ELKINS SINN 50MG/ML N84307 001 Mar CTEC PHENYTOIN SODIUM >D> @ HOSPIRA 50MG/ML N89744 001 Dec 18, 1987 Mar CMFD >A> AP 50MG/ML N89744 001 Dec 18, 1987 Mar CMFD >D> @ 50MG/ML N89521 001 Mar 17, 1987 Mar CMFD >A> AP 50MG/ML N89521 001 Mar 17, 1987 Mar CMFD PIROXICAM CAPSULE; ORAL PIROXICAM >D> AB COPLEY PHARM 10MG N74103 001 Aug 28, 1992 Mar CAHN >D> AB 20MG N74103 002 Aug 28, 1992 Mar CAHN >A> AB TEVA PHARMS 10MG N74103 001 Aug 28, 1992 Mar CAHN >A> AB 20MG N74103 002 Aug 28, 1992 Mar CAHN POTASSIUM CHLORIDE INJECTABLE; INJECTION POTASSIUM CHLORIDE 10MEQ IN PLASTIC CONTAINER >D> @ HOSPIRA 14.9MG/ML N20161 005 Nov 30, 1992 Mar CMFD >A> AP 14.9MG/ML N20161 005 Nov 30, 1992 Mar CMFD >D> @ 745MG/100ML N20161 001 Nov 30, 1992 Mar CMFD >A> AP 745MG/100ML N20161 001 Nov 30, 1992 Mar CMFD POTASSIUM CHLORIDE 20MEQ IN PLASTIC CONTAINER >D> @ HOSPIRA 1.49GM/100ML N20161 002 Nov 30, 1992 Mar CMFD >A> AP 1.49GM/100ML N20161 002 Nov 30, 1992 Mar CMFD >A> PRAMLINTIDE ACETATE >A> INJECTABLE; SUBCUTANEOUS >A> SYMLIN >A> + AMYLIN EQ 3MG BASE/5ML (EQ 0.6MG BASE/ML) N21332 001 Mar 16, 2005 Mar NEWA PREDNISOLONE SYRUP; ORAL PREDNISOLONE >D> AA COPLEY PHARM 15MG/5ML N40322 001 Jan 19, 2000 Mar CAHN >A> AA TEVA PHARMS 15MG/5ML N40322 001 Jan 19, 2000 Mar CAHN PREDNISOLONE SODIUM PHOSPHATE SOLUTION; ORAL PEDIAPRED >D> AA + CELLTECH PHARMS EQ 5MG BASE/5ML N19157 001 May 28, 1986 Mar CAHN >A> AA + UCB EQ 5MG BASE/5ML N19157 001 May 28, 1986 Mar CAHN PROCHLORPERAZINE MALEATE TABLET; ORAL PROCHLORPERAZINE MALEATE >D> AB COPLEY PHARM EQ 5MG BASE N40120 001 Jul 11, 1996 Mar CAHN >D> AB EQ 10MG BASE N40120 002 Jul 11, 1996 Mar CAHN >A> AB TEVA PHARMS EQ 5MG BASE N40120 001 Jul 11, 1996 Mar CAHN >A> AB EQ 10MG BASE N40120 002 Jul 11, 1996 Mar CAHN PROPOFOL INJECTABLE; INJECTION PROPOFOL >A> AB BEDFORD 10MG/ML N74848 001 Apr 19, 2005 Mar NEWA QUINIDINE SULFATE TABLET, EXTENDED RELEASE; ORAL QUINIDINE SULFATE >D> + COPLEY PHARM 300MG N40045 001 Jun 30, 1994 Mar CAHN >A> + TEVA PHARMS 300MG N40045 001 Jun 30, 1994 Mar CAHN SODIUM CHLORIDE SOLUTION; IRRIGATION SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER >D> @ HOSPIRA 450MG/100ML N18380 001 Mar CMFD >A> AT 450MG/100ML N18380 001 Mar CMFD >D> SOMATREM >D> INJECTABLE; INJECTION >D> PROTROPIN >D> + GENENTECH 5MG/VIAL N19107 001 Oct 17, 1985 Mar DISC >A> @ 5MG/VIAL N19107 001 Oct 17, 1985 Mar DISC >D> + 10MG/VIAL N19107 002 Oct 24, 1989 Mar DISC >A> @ 10MG/VIAL N19107 002 Oct 24, 1989 Mar DISC TERBUTALINE SULFATE TABLET; ORAL TERBUTALINE SULFATE >A> AB LANNETT 2.5MG N77152 001 Mar 25, 2005 Mar NEWA >A> AB 5MG N77152 002 Mar 25, 2005 Mar NEWA TETRACYCLINE HYDROCHLORIDE CAPSULE; ORAL >D> SUMYCIN >D> AB APOTHECON 250MG N60429 001 Mar DISC >A> @ 250MG N60429 001 Mar DISC >D> AB + 500MG N60429 003 Mar DISC >A> @ 500MG N60429 003 Mar DISC TETRACYCLINE HCL >D> AB IVAX PHARMS 500MG N60704 002 Mar CRLD >A> AB + 500MG N60704 002 Mar CRLD THIORIDAZINE HYDROCHLORIDE CONCENTRATE; ORAL THIORIDAZINE HCL >D> AA + COPLEY PHARM 30MG/ML N89602 001 Nov 09, 1987 Mar CAHN >D> AA + 100MG/ML N89603 001 Nov 09, 1987 Mar CAHN >A> AA + TEVA PHARMS 30MG/ML N89602 001 Nov 09, 1987 Mar CAHN >A> AA + 100MG/ML N89603 001 Nov 09, 1987 Mar CAHN THIOTHIXENE HYDROCHLORIDE CONCENTRATE; ORAL THIOTHIXENE HCL >D> AA COPLEY PHARM EQ 5MG BASE/ML N71554 001 Oct 16, 1987 Mar CAHN >A> AA TEVA PHARMS EQ 5MG BASE/ML N71554 001 Oct 16, 1987 Mar CAHN TRETINOIN SOLUTION; TOPICAL TRETINOIN >D> AT COPLEY PHARM 0.05% N74873 001 Jun 19, 1998 Mar CAHN >A> AT TEVA PHARMS 0.05% N74873 001 Jun 19, 1998 Mar CAHN URSODIOL CAPSULE; ORAL URSODIOL >D> AB COPLEY PHARM 300MG N75592 001 May 25, 2000 Mar CAHN >A> AB TEVA PHARMS 300MG N75592 001 May 25, 2000 Mar CAHN VALPROIC ACID SYRUP; ORAL VALPROIC ACID >D> AA COPLEY PHARM 250MG/5ML N73178 001 Aug 25, 1992 Mar CAHN >A> AA TEVA PHARMS 250MG/5ML N73178 001 Aug 25, 1992 Mar CAHN VERAPAMIL HYDROCHLORIDE CAPSULE, EXTENDED RELEASE; ORAL VERELAN PM >D> + ELAN PHARM 100MG N20943 001 Nov 25, 1998 Mar CRLD >A> 100MG N20943 001 Nov 25, 1998 Mar CRLD >D> + 200MG N20943 002 Nov 25, 1998 Mar CRLD >A> 200MG N20943 002 Nov 25, 1998 Mar CRLD VINORELBINE TARTRATE INJECTABLE; INJECTION VINORELBINE TARTRATE >A> AP AM PHARM EQ 10MG BASE/ML N76849 001 Apr 18, 2005 Mar NEWA
ADDITIONS/DELETIONS FOR OTC DRUG PRODUCT LIST
ASPIRIN TABLET; ORAL BAYER EXTRA STRENGTH ASPIRIN FOR MIGRAINE PAIN >D> @ BAYER 500MG N21317 001 Oct 18, 2001 Mar CMFD >A> 500MG N21317 001 Oct 18, 2001 Mar CMFD CLOTRIMAZOLE TABLET; VAGINAL GYNIX >D> COPLEY PHARM 100MG N73249 001 Feb 13, 1998 Mar CAHN >A> TEVA PHARMS 100MG N73249 001 Feb 13, 1998 Mar CAHN FAMOTIDINE TABLET; ORAL FAMOTIDINE >A> PERRIGO 10MG N75400 001 Mar 18, 2005 Mar NEWA